Sfoglia per AUTORE
ASTEGIANO M
Collezione AOU Città della Salute di Torino

  

Items : 62

Follow-up evaluation and management of anemia in inflammatory bowel disease: A study by the Italian Group for Inflammatory Bowel Diseases (IG-IBD). in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver / Dig Liver Dis. 2024 Sep;56(9):1483-1489. doi: 10.1016/j.dld.2024.01.176. Epub 2024 Jan 30.
2024
ASL Città di Torino
ASL Torino 3
AOU Città della Salute di Torino

Klersy C; Di Sabatino A; Vecchi M; Testa A; Lenti MV; Mengoli C; Fiorino G; Aronico N; Villa E; Monica F; Manca A; Caprioli F; Buda A; Neri M; Riegler G; Mazzucco D; Bassotti G; Scribano ML; Bodini G; Ricci C; Principi M; Vernia P; Bossa F; Ciccocioppo R; Orlando A; Saibeni S; Ciacci C; Rizzello F; Fries W; et alii...

Overlapping approach Proton Pump Inhibitors/Nux vomica-Heel as new intervention for gastro-esophageal reflux management: Delphi consensus study. in World journal of gastroenterology / World J Gastroenterol. 2024 May 14;30(18):2467-2478. doi: 10.3748/wjg.v30.i18.2467.
2024
ASL Torino 4
AOU Città della Salute di Torino

Astegiano M; Monzani M; Del Prete M; Battaglia E; Bertolusso L;

Diagnostic delay in adult coeliac disease: An Italian multicentre study. in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver / Dig Liver Dis. 2023 Jun;55(6):743-750. doi: 10.1016/j.dld.2022.11.021. Epub 2022 Dec 23.
2023
AOU Città della Salute di Torino

Cesaro N; Efthymakis K; Onnis F; Rossi C; Alunno G; Gabba M; Mansueto P; Carrieri A; Lynch E; Santacroce G; Pilia R; Abenavoli L; Tomaselli D; Marinoni B; Bibbò S; Marsilio I; Ianiro G; Broglio G; Rossi CM; Vecchione N; Iannelli C; Quatraccioni C; Petrucci C; Latorre MA; Portincasa P; Gasbarrini A; Cammarota G; Fantini MC; Elli L; et alii...

2023
AO Ordine Mauriziano
AOU Città della Salute di Torino

Vineis P; Calvo PL; Bruno M; Astegiano M; Crocella L; Guiotto C; Stalla F; Francescato G; Grioni S; Sieri S; Caviglia GP; Zanatto L; Tarallo S; Pardini B; Francavilla A; Ferrero G; Ribaldone DG; Naccarati A;

Prevalence, Pathogenesis and Management of Anemia in Inflammatory Bowel Disease: An IG-IBD Multicenter, Prospective, and Observational Study. in Inflammatory bowel diseases / Inflamm Bowel Dis. 2023 Jan 5;29(1):76-84. doi: 10.1093/ibd/izac054.
2023
AOU Città della Salute di Torino
ASL Torino 3

Bergamaschi G; Castiglione F; D'Incà R; Astegiano M; Fries W; Milla M; Ciacci C; Rizzello F; Saibeni S; Ciccocioppo R; Orlando A; Bossa F; Principi M; Vernia P; Ricci C; Scribano ML; Bodini G; Mazzucco D; Bassotti G; Riegler G; Buda A; Neri M; Caprioli F; Monica F; Manca A; Villa E; Fiorino G; Comberlato M; Aronico N; et alii...

Epidemiology of Inflammatory Bowel Diseases: A Population Study in a Healthcare District of North-West Italy. in Journal of clinical medicine / J Clin Med. 2023 Jan 13;12(2):641. doi: 10.3390/jcm12020641.
2023
ASL Cuneo 2
AOU Città della Salute di Torino

Saracco GM; Astegiano M; Armandi A; Frara S; Tribocco E; Poshnjari A; Bretto E; Vanni R; Bertolino C; Garrone A; Caviglia GP; Bertolusso L; Ribaldone DG;

The recipe for the perfect inflammatory bowel disease nurse in a northern Italy tertiary IBD center: going beyond clinical care. in Minerva gastroenterology / Minerva Gastroenterol (Torino). 2022 Dec;68(4):375-377. doi: 10.23736/S2724-5985.22.03179-5. Epub 20
2022
AOU Città della Salute di Torino

Pellicano R; Astegiano M; Ribaldone DG; Vernero M;

Predictive Factors of Surgical Recurrence in Patients with Crohn's Disease on Long-Term Follow-Up: A Focus on Histology. in Journal of clinical medicine / J Clin Med. 2022 Aug 27;11(17):5043. doi: 10.3390/jcm11175043.
2022
AOU Città della Salute di Torino

Caviglia GP; Mineo CA; Rosso C; Armandi A; Astegiano M; Canavese G; Resegotti A; Saracco GM; Ribaldone DG;

Late is too late? Surgical timing and postoperative complications after primary ileocolic resection for Crohn's disease. in International journal of colorectal disease / Int J Colorectal Dis. 2022 Apr;37(4):843-848. doi: 10.1007/s00384-022-04125-7. Epub 2022 Mar 10.
2022
AOU Città della Salute di Torino

Morino M; Astegiano M; Ammirati CA; Allaix ME; Lavorini E; Resegotti A;

Intestinal microbiota changes induced by TNF-inhibitors in IBD-related spondyloarthritis. in RMD open / RMD Open. 2021 Sep;7(3):e001755. doi: 10.1136/rmdopen-2021-001755.
2021
AOU Città della Salute di Torino

Ditto MC; Parisi S; Landolfi G; Borrelli R; Realmuto C; Finucci A; Caviglia GP; Ribaldone DG; Astegiano M; Zanetti A; Carrara G; Scirè CA; Antivalle M; Sarzi-Puttini P; Fusaro E;

2021
AOU Città della Salute di Torino

Caviglia GP; De Blasio F; Vernero M; Armandi A; Rosso C; Saracco GM; Bugianesi E; Astegiano M; Ribaldone DG;

Inflammatory bowel disease course in liver transplant versus non-liver transplant patients for primary sclerosing cholangitis: LIVIBD, an IG-IBD study. in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver / Dig Liver Dis. 2021 Jun;53(6):712-716. doi: 10.1016/j.dld.2020.09.011. Epub 2020 Sep 21.
2021
AOU Città della Salute di Torino

Romagnoli R; Saracco GM; Salizzoni M; Vecchi M; Milla M; Castiglione F; Sarli E; Reggio D; Boano V; Mosso E; Fagoonee S; Balestrieri P; De Blasio F; Furfaro F; Le Grazie M; Imperatore N; Ribaldone DG; Fiorino G; Astegiano M;

Switching from Biosimilar to Biosimilar Adalimumab, Including Multiple Switching, in Crohn's Disease: A Prospective Study. in Journal of clinical medicine / J Clin Med. 2021 Jul 30;10(15):3387. doi: 10.3390/jcm10153387.
2021
AOU Città della Salute di Torino

Ribaldone DG; Tribocco E; Rosso C; Armandi A; Vernero M; Bugianesi E; Astegiano M; Saracco GM; Caviglia GP;

Risk Factors of Urothelial Cancer in Inflammatory Bowel Disease. in Journal of clinical medicine / J Clin Med. 2021 Jul 23;10(15):3257. doi: 10.3390/jcm10153257.
2021
AOU Città della Salute di Torino

Caviglia GP; Martini G; Armandi A; Rosso C; Vernero M; Bugianesi E; Astegiano M; Saracco GM; Ribaldone DG;

A randomized, double-blind, placebo-controlled pilot study to evaluate the efficacy and tolerability of a novel oral bioadhesive formulation for the treatment of nonerosive reflux disease-related symptoms. in European journal of gastroenterology & hepatology / Eur J Gastroenterol Hepatol. 2021 Feb 1;32(2):163-170. doi: 10.1097/MEG.0000000000001888.
2021
AOU Città della Salute di Torino

Ribaldone DG; Rajesh P; Chandradhara D; Astegiano M; Pellicano R;

Effectiveness and safety of switching to adalimumab biosimilar ABP 501 in Crohn's disease: the extrapolation concept. in Revista espanola de enfermedades digestivas / Rev Esp Enferm Dig. 2021 Feb;113(2):155. doi: 10.17235/reed.2020.7253/2020.
2021
AOU Città della Salute di Torino

Ribaldone DG; Vernero M; Astegiano M;

2021
AOU Città della Salute di Torino

Ponzo V; Ferrocino I; Goitre I; Pellegrini M; Bruno M; Astegiano M; Cadario G; Castellana E; Bioletto F; Corvaglia MR; Malfa P; Cocolin L; Ghigo E; Bo S;

Inflammatory Bowel Disease Nurse-Practical Messages. in Nursing reports (Pavia, Italy) / Nurs Rep. 2021 Apr 1;11(2):229-241. doi: 10.3390/nursrep11020023.
2021
AOU Città della Salute di Torino

Rosso C; Aaron AA; Armandi A; Caviglia GP; Vernero M; Saracco GM; Astegiano M; Bugianesi E; Ribaldone DG;

Proctitis: a glance beyond inflammatory bowel diseases. in Minerva gastroenterologica e dietologica / Minerva Gastroenterol Dietol. 2020 Sep;66(3):252-266. doi: 10.23736/S1121-421X.20.02670-7. Epub 2020
2020
AOU Città della Salute di Torino

Pellicano R; Saracco GM; Astegiano M; Morino M; Ribaldone DG; Mistrangelo M; Rizza S;

Management of inflammatory bowel disease during COVID-19 pandemic. in Minerva gastroenterologica e dietologica / Minerva Gastroenterol Dietol. 2020 Sep;66(3):184-186. doi: 10.23736/S1121-421X.20.02707-5. Epub 2020
2020
AOU Città della Salute di Torino

Ribaldone DG; Astegiano M; Actis GC; Pellicano R; Ribaldone DG; Astegiano M; Actis GC; Pellicano R;

Interstitial and Granulomatous Lung Disease in Inflammatory Bowel Disease Patients. in Journal of Crohn's & colitis / J Crohns Colitis. 2020 May 21;14(4):480-489. doi: 10.1093/ecco-jcc/jjz165.
2020
AOU Città della Salute di Torino

Eliadou E; Moleiro J; Ribaldone DG; Astegiano M; Rothfuss K; Taxonera C; Ghalim F; Carbonnel F; Verstockt B; Festa S; Maia L; Berrozpe A; Zagorowicz E; Savarino E; Ellul P; Vavricka SR; Calvo M; Koutroubakis I; Hoentjen F; Salazar LF; Callela F; Cañete Pizarro F; Soufleris K; Sonnenberg E; Cavicchi M; Wypych J; Hommel C; Ghiani A; Fiorino G; et alii...

2020
AOU Città della Salute di Torino

Caviglia GP; Rosso C; Stalla F; Rizzo M; Massano A; Abate ML; Olivero A; Armandi A; Vanni E; Younes R; Fagoonee S; Pellicano R; Astegiano M; Saracco GM; Bugianesi E; Ribaldone DG;

Effectiveness and safety of adalimumab biosimilar ABP 501 in Crohn's disease: an observational study. in Revista espanola de enfermedades digestivas / Rev Esp Enferm Dig. 2020 Mar;112(3):195-200. doi: 10.17235/reed.2020.6693/2019.
2020
AOU Città della Salute di Torino

Ribaldone DG; Caviglia GP; Pellicano R; Vernero M; Saracco GM; Morino M; Astegiano M;

Risk of incident melanoma in patients with inflammatory disease treated with anti-TNF: the Turin experience. in Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia / G Ital Dermatol Venereol. 2020 Jun;155(3):366-367. doi: 10.23736/S0392-0488.18.06017-0. Epub 2018 Se
2020
AOU Città della Salute di Torino

Pellicano R; Astegiano M; Ribaldone DG; Vernero M;

Role of Compositum Zeolite® in management of inflammatory bowel disease: a pilot study. in Minerva gastroenterologica e dietologica / Minerva Gastroenterol Dietol. 2020 Jun;66(2):113-116. doi: 10.23736/S1121-421X.20.02682-3.
2020
AOU Città della Salute di Torino

Vernero M; Di Leo I; Givone M; Adriani A; Bergamaschi A; Fanelli M; Astegiano M;

2020
AOU Città della Salute di Torino

Caviglia GP; Tucci A; Pellicano R; Fagoonee S; Rosso C; Abate ML; Olivero A; Armandi A; Vanni E; Saracco GM; Bugianesi E; Astegiano M; Ribaldone DG;

PD-L1 in small bowel adenocarcinoma is associated with etiology and tumor-infiltrating lymphocytes, in addition to microsatellite instability. in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc / Mod Pathol. 2020 Jul;33(7):1398-1409. doi: 10.1038/s41379-020-0497-0. Epub 2020 Feb 17.
2020
AOU Città della Salute di Torino
ASL Biella

Silano M; Usai P; Sandri G; Quaquarini E; Perfetti V; Papi C; Giannone AG; Orlandi A; Cantoro L; Biletta E; Astegiano M; Reggiani Bonetti L; Oreggia B; Lenti MV; Zingone F; D'Odorico A; D'Incà R; Caprioli F; Vecchi M; Ciardi A; Elli L; Caronna R; Monteleone G; Biancone L; Florena AM; Canzonieri V; Cannizzaro R; Villanacci V; Tonelli F; et alii...

Correction: PD-L1 in small bowel adenocarcinoma is associated with etiology and tumor-infiltrating lymphocytes, in addition to microsatellite instability. in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc / Mod Pathol. 2020 Jul;33(7):1453. doi: 10.1038/s41379-020-0512-5.
2020
AOU Città della Salute di Torino
ASL Biella

Giuffrida P; Arpa G; Grillo F; Klersy C; Sampietro G; Ardizzone S; Fociani P; Fiocca R; Latella G; Sessa F; D'Errico A; Malvi D; Mescoli C; Rugge M; Nesi G; Ferrero S; Furlan D; Poggioli G; Rizzello F; Macciomei MC; Santini D; Volta U; De Giorgio R; Caio G; Calabrò A; Ciacci C; D'Armiento M; Rizzo A; Solina G; et alii...

Vedolizumab for treatment of chronic refractory pouchitis: a systematic review with pool analysis. in Revista espanola de enfermedades digestivas / Rev Esp Enferm Dig. 2020 Jan;112(1):59-63. doi: 10.17235/reed.2019.6336/2019.
2020
AOU Città della Salute di Torino

Ribaldone DG; Pellicano R; Saracco GM; Morino M; Astegiano M;

2020
AOU Città della Salute di Torino

Vernero M; De Blasio F; Ribaldone DG; Bugianesi E; Pellicano R; Saracco GM; Astegiano M; Caviglia GP;

Adalimumab Therapy Improves Intestinal Dysbiosis in Crohn's Disease. in Journal of clinical medicine / J Clin Med. 2019 Oct 9;8(10):1646. doi: 10.3390/jcm8101646.
2019
AOU Città della Salute di Torino

Ribaldone DG; Caviglia GP; Abdulle A; Pellicano R; Ditto MC; Morino M; Fusaro E; Saracco GM; Bugianesi E; Astegiano M;

Risk factors of suspected spondyloarthritis among inflammatory bowel disease patients. in Scandinavian journal of gastroenterology / Scand J Gastroenterol. 2019 Oct;54(10):1233-1236. doi: 10.1080/00365521.2019.1668052. Epub 2019 Sep
2019
AOU Città della Salute di Torino

Ribaldone DG; Vernero M; Parisi S; Ditto MC; Pellicano R; Morino M; Saracco GM; Fusaro E; Astegiano M;

Integrated serum proteins and fatty acids analysis for putative biomarker discovery in inflammatory bowel disease. in Journal of proteomics / J Proteomics. 2019 Mar 20;195:138-149. doi: 10.1016/j.jprot.2018.10.017. Epub 2018 Nov 2.
2019
AOU Città della Salute di Torino

De Andrea M; Marengo E; Gariglio M; Astegiano M; Brandi J; Vanni E; Finocchiaro M; Cecconi D; Caneparo V; Buzzi A; Robotti E; Conte E; Barberis E; Manfredi M; Manfredi M; Conte E; Barberis E; Buzzi A; Robotti E; Caneparo V; Cecconi D; Brandi J; Vanni E; Finocchiaro M; Astegiano M; Gariglio M; Marengo E; De Andrea M;

The role of topical therapy for perianal fistulizing Crohn's disease: are we forgetting something? in Minerva gastroenterologica e dietologica / Minerva Gastroenterol Dietol. 2019 Jun;65(2):130-135. doi: 10.23736/S1121-421X.19.02565-0. Epub 2019
2019
AOU Città della Salute di Torino

Ribaldone DG; Resegotti A; Pellicano R; Astegiano M; Saracco GM; Morino M;

Apparent diffusion coefficient and enhancement patterns in MR imaging as markers of severe or moderate ileum inflammation in Crohn's disease. in Revista espanola de enfermedades digestivas / Rev Esp Enferm Dig. 2019 Jan;111(1):28-33. doi: 10.17235/reed.2018.5691/2018.
2019
AOU Città della Salute di Torino

Faletti R; Ribaldone DG; Gatti M; Perazzini C; Robella M; Angelino F; Saracco GM; Astegiano M; Pellicano R; Fonio P;

New Onset of Inflammatory Bowel Disease in Three Patients Undergoing IL-17A Inhibitor Secukinumab: A Case Series. in The American journal of gastroenterology / Am J Gastroenterol. 2019 Jan;114(1):179-180. doi: 10.1038/s41395-018-0422-z.
2019
AOU Città della Salute di Torino

Vernero M; Astegiano M; Ribaldone DG;

The therapy of chronic pouchitis. in Minerva gastroenterologica e dietologica / Minerva Gastroenterol Dietol. 2019 Dec;65(4):265-267. doi: 10.23736/S1121-421X.18.02551-5. Epub 2019
2019
AOU Città della Salute di Torino

Astegiano M; Resegotti A; Ribaldone DG;

Correlation between Thiopurine S-Methyltransferase Genotype and Adverse Events in Inflammatory Bowel Disease Patients. in Medicina (Kaunas, Lithuania) / Medicina (Kaunas). 2019 Aug 5;55(8):441. doi: 10.3390/medicina55080441.
2019
ASL Città di Torino
AOU Città della Salute di Torino

Luzza F; D'Avolio A; Perri GD; Canaparo R; Pellicano R; Riganò D; Simiele M; Agnesod D; Nicolò A; Caviglia GP; Adriani A; Ribaldone DG; Saracco GM; Astegiano M;

Serum zonulin in patients with inflammatory bowel disease: a pilot study. in Minerva medica / Minerva Med. 2019 Apr;110(2):95-100. doi: 10.23736/S0026-4806.18.05787-7. Epub 2018 Aug 28.
2019
AOU Città della Salute di Torino

Saracco GM; Smedile A; Bresso F; Abate ML; Pellicano R; Rosso C; Dughera F; Ribaldone DG; Caviglia GP; Astegiano M; Caviglia GP; Dughera F; Ribaldone DG; Rosso C; Abate ML; Pellicano R; Bresso F; Smedile A; Saracco GM; Astegiano M;

Management of Helicobacter pylori in Piedmont, Italy. in Minerva gastroenterologica e dietologica / Minerva Gastroenterol Dietol. 2018 Sep;64(3):235-250. doi: 10.23736/S1121-421X.18.02483-2. Epub 2018
2018
AO Cuneo
ASL Torino 3
AO Ordine Mauriziano
AOU Città della Salute di Torino

Ribaldone DG; Simondi D; Rocca R; Caviglia GP; Fracchia M; Crocellà L; Lavagna A; Mazzucco D; Fagoonee S; Astegiano M; Ribaldone DG; Mazzucco D; Fagoonee S; Crocellà L; Lavagna A; Fracchia M; Caviglia GP; Simondi D; Rocca R; Astegiano M;

Severe ulcerative colitis: predictors of response and algorithm proposal for rescue therapy. in Irish journal of medical science / Ir J Med Sci. 2018 May;187(2):385-392. doi: 10.1007/s11845-017-1666-0. Epub 2017 Jul 29.
2018
AOU Città della Salute di Torino

Saracco G; Vernero M; Fagoonee S; Resegotti A; Pellicano R; Dileo I; Ribaldone DG; Astegiano M;

Fecal calprotectin: beyond intestinal organic diseases. in Panminerva medica / Panminerva Med. 2018 Mar;60(1):29-34. doi: 10.23736/S0031-0808.18.03405-5. Epub 2018 Jan 25.
2018
AOU Città della Salute di Torino

Caviglia GP; Ribaldone DG; Rosso C; Saracco GM; Astegiano M; Pellicano R;

Helicobacter pylori eradication: poor medical compliance from East to West of the world. in Scandinavian journal of gastroenterology / Scand J Gastroenterol. 2018 Mar;53(3):265. doi: 10.1080/00365521.2018.1433231. Epub 2018 Jan 31.
2018
AOU Città della Salute di Torino

Ribaldone DG; Astegiano M; Pellicano R;

Letter: biologics treatment in Crohn's disease and risk of bowel resection-what about the patients who stop anti-TNF therapy? in Alimentary pharmacology & therapeutics / Aliment Pharmacol Ther. 2018 Jan;47(1):146-147. doi: 10.1111/apt.14321.
2018
AOU Città della Salute di Torino

Ribaldone DG; Saracco G; Astegiano M; Pellicano R;

The adherence to the therapy in inflammatory bowel disease: beyond the number of the tablets. in Scandinavian journal of gastroenterology / Scand J Gastroenterol. 2018 Feb;53(2):141-146. doi: 10.1080/00365521.2017.1405070. Epub 2017 Dec 11.
2018
AOU Città della Salute di Torino

Caviglia GP; Finocchiaro F; Pellicano R; Saracco GM; Vernero M; Ribaldone DG; Astegiano M;

Letter: therapeutic drug monitoring and inflammatory bowel disease-a call for an urgent standardization of the results. in Alimentary pharmacology & therapeutics / Aliment Pharmacol Ther. 2018 Feb;47(3):448-449. doi: 10.1111/apt.14456.
2018
AOU Città della Salute di Torino

Ribaldone DG; Saracco GM; Astegiano M; Pellicano R;

Gastroenterology today: between certainties and news. in Minerva gastroenterologica e dietologica / Minerva Gastroenterol Dietol. 2018 Dec;64(4):323-332. doi: 10.23736/S1121-421X.18.02465-0. Epub 2018
2018
ASL Asti
AOU Città della Salute di Torino

Saracco GM; Grassini M; Arrigoni A; Spandre M; Morgando A; Dughera L; Battaglia E; Astegiano M; Mégraud F; Ribaldone DG; Pellicano R; Pellicano R; Ribaldone DG; Astegiano M; Dughera L; Battaglia E; Morgando A; Arrigoni A; Spandre M; Grassini M; Saracco GM; Mégraud F;

How ameliorate the adherence in patients with inflammatory bowel disease? in Scandinavian journal of gastroenterology / Scand J Gastroenterol. 2018 Aug;53(8):938-939. doi: 10.1080/00365521.2018.1485731. Epub 2018 Jul 3.
2018
AOU Città della Salute di Torino

Ribaldone DG; Vernero M; Astegiano M; Pellicano R; Ribaldone DG; Vernero M; Astegiano M; Pellicano R;

Comment #2 on "First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin". in Gastroenterology research and practice / Gastroenterol Res Pract. 2018 Dec 16;2018:5260358. doi: 10.1155/2018/5260358. eCollection 2018.
2018
AOU Città della Salute di Torino

Astegiano M; Ribaldone DG; Ribaldone DG; Astegiano M;

The role of hepatic enzymes in Crohn's disease. in International journal of colorectal disease / Int J Colorectal Dis. 2017 Sep;32(9):1363-1364. doi: 10.1007/s00384-017-2829-1. Epub 2017 May 4.
2017
AOU Città della Salute di Torino

Pellicano R; Astegiano M; Ribaldone DG;

Features of inflammatory bowel disease followed in a second level center in Northern Italy. in Minerva medica / Minerva Med. 2017 Oct;108(5):481-482. doi: 10.23736/S0026-4806.17.05118-7.
2017
AOU Città della Salute di Torino

Ribaldone DG; Simondi D; Manca A; Demarchi B; Pulitanò R; Astegiano M; Pellicano R;

Gastric emptying and related symptoms in patients treated with buspirone, amitriptyline or clebopride: a "real world" study by 13C-octanoic Acid Breath Test. in Minerva medica / Minerva Med. 2017 Dec;108(6):489-495. doi: 10.23736/S0026-4806.17.05320-4. Epub 2017 Jul 12.
2017
AOU Città della Salute di Torino

Caviglia GP; Sguazzini C; Cisarò F; Ribaldone DG; Rosso C; Fagoonee S; Smedile A; Saracco GM; Astegiano M; Pellicano R;

Biosimilar CT-P13 in treating ulcerative colitis in the real world. in Minerva gastroenterologica e dietologica / Minerva Gastroenterol Dietol. 2017 Dec;63(4):305-306. doi: 10.23736/S1121-421X.17.02423-0.
2017
AOU Città della Salute di Torino

Ribaldone DG; Astegiano M;

2017
ASL Vercelli
AOU Città della Salute di Torino

Coppola L; Papi C; Giannone AG; Florena AM; Sandri G; Silano M; Perfetti V; D'Incà R; Macciomei MC; Santeusanio G; Orlandi A; Monteleone G; Biancone L; Reggiani Bonetti L; Cannizzaro R; Canzonieri V; Villanacci V; Salemme M; D'Armiento FP; Ciacci C; Rizzo A; Solina G; Caronna R; Ciardi A; Latella G; Ferrero S; Elli L; Caio G; Giuffrida P; et alii...

On Inverse Association Between Helicobacter pylori Gastritis and Microscopic Colitis: The European Data. in Inflammatory bowel diseases / Inflamm Bowel Dis. 2016 Mar;22(3):E11-2. doi: 10.1097/MIB.0000000000000704.
2016
AO Cuneo
AOU Città della Salute di Torino

Simondi D; Astegiano M; Ribaldone DG; Pellicano R;

A preserved stratified pattern of the bowel wall 1 year after major surgery does not influence the surgical recurrence of Crohn's disease. in Irish journal of medical science / Ir J Med Sci. 2016 Feb;185(1):269-70. doi: 10.1007/s11845-015-1249-x. Epub 2015 Jan 13.
2016
AOU Città della Salute di Torino

Astegiano M; Resegotti A; Cammarota T; Ribaldone DG;

Adnexal localization of Crohn's disease and recurrent massive ovary cysts. in Revista espanola de enfermedades digestivas / Rev Esp Enferm Dig. 2016 Aug;108(8):525-6. doi: 10.17235/reed.2016.4301/2016.
2016
AOU Città della Salute di Torino

Ribaldone DG; Conti L; Resegotti A; Astegiano M;

A Case of Intestinal Mastocytosis Misdiagnosed as Crohn's Disease. in Case reports in gastroenterology / Case Rep Gastroenterol. 2015 Jun 3;9(2):188-93. doi: 10.1159/000430946. eCollection 2015 May-Aug.
2015
AOU Città della Salute di Torino

Reggiani S; Cosso L; Adriani A; Pantaleoni S; Risso A; Vittone F; Chiusa L; Sapone N; Astegiano M;

Power Doppler sonography to predict the risk of surgical recurrence of Crohn's disease. in Journal of ultrasound / J Ultrasound. 2014 Jun 12;18(1):51-5. doi: 10.1007/s40477-014-0101-x. eCollection 2015 Mar.
2015
AOU Città della Salute di Torino

Sguazzini C; Adriani A; Pellicano R; Bresso F; Bonenti G; Debani P; Robotti D; Sarno A; Resegotti A; Cammarota T; Ribaldone DG; Reggiani S; Astegiano M;

The mesenteric flap: a technique for pelvic closure after proctectomy for Crohn's disease. in Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland / Colorectal Dis. 2015 Jun;17(6):543-4. doi: 10.1111/codi.12973.
2015
AOU Città della Salute di Torino

Silvestri S; Falcone A; Franchello A; Guglielmino V; Cassine D; Astegiano M; Resegotti A;

Prevalence and prognostic value of hepatic histological alterations in patients with Crohn's disease. in Scandinavian journal of gastroenterology / Scand J Gastroenterol. 2015;50(12):1463-8. doi: 10.3109/00365521.2015.1064995. Epub 2015 Jul 2.
2015
AOU Città della Salute di Torino

Ribaldone DG; Garavagno M; Pellicano R; Bresso F; Fagoonee S; David E; Sapone N; Bonagura AG; Resegotti A; Astegiano M;

Glucose breath test and Crohn's disease: Diagnosis of small intestinal bacterial overgrowth and evaluation of therapeutic response. in Scandinavian journal of gastroenterology / Scand J Gastroenterol. 2015;50(11):1376-81. doi: 10.3109/00365521.2015.1050691. Epub 2015 May 19.
2015
AOU Città della Salute di Torino

Greco A; Caviglia GP; Brignolo P; Ribaldone DG; Reggiani S; Sguazzini C; Smedile A; Pellicano R; Resegotti A; Astegiano M; Bresso F;